science_technology_and_other_research_and_development · DOD-AMRAA

DoW Ovarian Cancer, Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA · HT942526OCRPCTA

37 days left

Total Program Funding

$5.6M

Expected Awards

Deadline

October 1, 2026

GRANTQUICK SUMMARYPlain-English Overview

DoW Ovarian Cancer, Clinical Trial Award. Defense Health Agency Contracting Activity - DHACA. Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Distinctive Features: Clinical trials may be designed to evaluate promising new products,... $5,600,000 total program funding; ~2 awards expected.

Who Should Apply

Unrestricted (any eligible entity)

Who Should NOT Apply

Few restrictions — most eligible entities can apply

Key Requirements (Plain English)

•Deadline: 2026-10-01

💡 GrantQuick Tip

High-value award — invest significantly in proposal quality. Consider hiring a grant writer.

Competitiveness: Very high — extremely limited awards available

What This Grant Funds

Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.

Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.